Xeomin™
Active ingredients: incobotulinumtoxinA
Consumer medicine information
Read the CMI leaflet (Opens in new tab) for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
Xeomin is indicated in adults for the treatment of: Cervical dystonia (spasmodic torticollis) Blepharospasm Spasticity of the upper limb Unilateral spasticity of the lower limb affecting the ankle joint. Chronic sialorrhea due to neurological disorders Upper facial lines - Glabellar frown lines - Lateral periorbital lines (crows feet) - Horizontal forehead lines Xeomin is indicated in children and adolescents aged 2 years to 17 years for the symptomatic treatment of: Chronic sialorrhea due to neurological/neurodevelopmental disorders Spasticity of the lower and/or upper limbs
Source: ARTG
Storage conditions
- Shelf lifetime is 36 Months
- Store below 30 degrees Celsius
- Store in Original Container
Source: ARTG
How to use this medicine
Non-composite pack
This medicine contains one component only.
Component
- Injection, powder for
- Intramuscular
- Powder for injection, white to off-white solid, supplied in a glass vial closed with a rubber stopper and sealed with an aluminium cap
Source: ARTG
Do I need a prescription?
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.
- 100 LD50 Units
Source: ARTG
Is this medicine subsidised?
This medicine was verified as available on the Pharmaceutical Benefits Scheme (PBS) on 1 November 2026, under the following PBS item codes:
- 11005F (Opens in new tab)
- 12087E (Opens in new tab)
- 10994P (Opens in new tab)
- 15226J (Opens in new tab)
- 15247L (Opens in new tab)
- 15307P (Opens in new tab)
- 15319G (Opens in new tab)
- 15574Q (Opens in new tab)
Ask your pharmacist or doctor about your eligibility
Source: PBS
Pregnant or planning a pregnancy?
For the active ingredient: incobotulinumtoxinA
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Source: AHT
Data sources
- Australian Health Thesaurus (AHT) (Opens in new tab) – Last updated on 4 November 2026
- Australian Medicines Terminology (AMT) (Opens in new tab) – Last updated on 4 November 2026
- Australian Register of Therapeutic Goods (ARTG) (Opens in new tab) – Last updated on 4 November 2026
- Pharmaceutical Benefits Scheme (PBS) (Opens in new tab) – Last updated on 4 November 2026
- Medicines Information Pty Ltd (Opens in new tab) – Last updated on 4 November 2026
Disclaimer
Healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions (Opens in new tab).
Symptom Checker
Worried about your health?
Select a symptom, answer some questions, get advice
